ArticleFrontiers in cell and developmental biology2025

Dendritic cell-derived MYD88 potentiates as a biomarker for immune regulation in hepatocellular carcinoma and may predict a better immunological result.

Zheming Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.